<DOC>
	<DOCNO>NCT00044642</DOCNO>
	<brief_summary>This study compare effect acute dose lorazepam placebo elderly patient generalize anxiety disorder ( GAD ) .</brief_summary>
	<brief_title>Lorazepam-Induced Toxicity Aged</brief_title>
	<detailed_description>GAD among common anxiety disorder elderly population . The drug lorazepam widely utilized treatment elderly individual GAD . However , single dos lorazepam associate cognitive toxicity typically evident 1 2.5 hour drug administer . The toxic effect include decreased memory increase swaying , associate great risk fall . Patients 4 study visit . A psychiatric evaluation memory test give first visit . During second study visit , patient physical exam , electrocardiogram ( ECG ) , neuropsychological assessment , optional magnetic resonance imaging ( MRI ) brain scan , laboratory test . On third fourth visit , patient randomize receive either high daily dose lorazepam placebo . Performance effect postural sway determine drug administration 1 , 2.5 , 5 hour drug give . Blood sample determination drug level also obtain .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Anxiety Disorders</mesh_term>
	<mesh_term>Lorazepam</mesh_term>
	<criteria>Lorazepam treatment least 3 month Cognitively intact Note : Individuals unable unwilling MRI may include Major psychiatric disorder GAD Significant medical illness may increase likelihood adverse reaction lorazepam Severe loss hear vision Current past history alcohol dependence Substance abuse within past 6 month MRI evidence infection , infarction , lesion suggestive intervene neurological disease Clinical symptom suggest neurological disease Dementia mental syndrome disorder</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>Anxiety</keyword>
</DOC>